liver disease

Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no current cure, but a drug called resmetirom may offer a lifeline for millions of patients, promoting a better quality of life and increased longevity.
After being bitten by a mosquito, who among us hasn’t been tormented by the resulting itch? Now, imagine that intensity and urge to scratch spread over your entire body, in a constant and unrelenting fashion – night and day. This condition has a name: chronic generalized pruritus.
A new study published in JAMA details the U.S. county-level trends in mortality rates for major causes of death. While a bit flawed, it's a step in the right direction as regional health disparity is often way more vital to informing policy than national tendencies.
A new CDC report reveals surprising and disturbing findings regarding overall death rates in America. They were found to have risen last year, albeit slightly, as compared to the year before. The cause, or causes, of this upturn are unknown, but should be pursued.
It is hardly news that Sovaldi and Harvoni, the enormously effective new hepatitis C drugs, are quite costly. This has caused some debate about when it is best to start using them. But, a new study says: "The sooner the better." It is better to treat patients before liver fibrosis is present.
A review of government statistics by two Princeton economists reveals a disturbing, and surprising, rising trend of mortality rates among middle-aged white Americans. The likely causes: drugs, both legal and illicit, liver diseases, alcohol and suicide.